A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist
Open accessThe DOI matches its Crossref record.
Abstract
Hepatocyte growth factor (HGF) activates the Met receptor tyrosine kinase by binding and promoting receptor dimerization. Here we describe a mechanistic basis for designing Met antagonists based on NK1, a natural variant of HGF containing the N-terminal and the first kringle domain. Through detailed biochemical and structural analyses, we demonstrate that both mouse and human NK1 induce Met dimerization via a conserved NK1 dimer interface. Mutations designed to alter the NK1 dimer interface abolish its ability to promote Met dimerization but retain full Met-binding activity. Importantly, these NK1 mutants act as Met antagonists by inhibiting HGF-mediated cell scattering, proliferation, branching, and invasion. The ability to separate the Met-binding activity of NK1 from its Met dimerization activity thus provides a rational basis for designing Met antagonists. This strategy of antagonist design may be applicable for other growth factor receptors by selectively abolishing the receptor activation ability but not the receptor binding of the growth factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Targeting MET in cancer: rationale and progress
Gherardi, E., Birchmeier, W., Birchmeier, C., & Woude, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3205 · Cited by 1,423
Self-citationHota, P. K., & Buck, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1019-0 · Cited by 170
MET: A Critical Player in Tumorigenesis and Therapeutic Target
Graveel, C. R., Tolbert, D., & Vande Woude, G. F. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009209 · Cited by 128
“The discoveryof these alternative ligand– receptor interactions has led to the development of a number of HGF/SF-based agonist/ antagonist derivatives that may have therapeutic value in wound healing or cancer treatment (Lietha et al. 2001; Tolbert et al. 2007; Youles et al. 2008).”
BackgroundDeakin, J. A., Blaum, B. S., Gallagher, J. T., Uhrín, D., & Lyon, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807671200 · Cited by 60
Nanoscale mapping of the Met receptor on hippocampal neurons by AFM and confocal microscopy
Kawas, L. H., Benoist, C. C., Harding, J. W., Wayman, G. A., & Abu-Lail, N. I. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.08.008 · Cited by 13
Metadata
- Authors
- Tolbert, W. D., Daugherty, J., Gao, C., Xie, Q., Miranti, C., Gherardi, E., Vande Woude, G., & Xu, H. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-09-11
- Volume
- 104
- Issue
- 37
- Pages
- 14592-14597
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1998771612
- Cited by
- 55
- References
- 0
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist. https://app.cochat.ai/papers/10.1073/pnas.0704290104
- The paper
- Tolbert, W. D., Daugherty, J., Gao, C., Xie, Q., Miranti, C., Gherardi, E., Vande Woude, G., & Xu, H. E. (2007). A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0704290104
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.